Get started
Author

Antoni Camins

Observed names: A Camins, A. Camins, ANTONI CAMINS, Antoni Camins Espuny, Antoni Camins-Espuny, Antonio Camins, Antonio Camins Espuny, C. Antoni, Camins A., Camins Antoni, Camins, A., Camins, Antoni, antoni camins
Observed institutions: Universitat Autònoma de Barcelona, Consejo Superior de Investigaciones Científicas, Universidade do Porto, Instituto de Salud Carlos III, Universidad Autónoma de Chile, Universitat Internacional de Catalunya, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut de Recerca Biomèdica Catalunya Sud, Centro de Investigación Biomédica en Red, Universidad Nacional de Loja, Institut d'Investigacions Biomèdiques de Barcelona, Rede de Química e Tecnologia, Hospital Universitari Sant Joan de Reus, Institut de Biomedicina de la Universitat de Barcelona, Universitat Rovira i Virgili, Universitat de Barcelona, University of Coimbra
ORCID: 0000-0002-1229-5956
Observed ORCID: 0000-0002-1229-5956
OpenAlex ID: A5073770071
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
2020 · Elena Sánchez-López, Daniela Gomes, et al. · Nanomaterials · 1,467
PDF
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
2019 · Amanda Cano, Miren Ettcheto, et al. · Journal of Controlled Release · 337
PDF
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
2018 · Elena Sánchez-López, Miren Ettcheto, et al. · Journal of Nanobiotechnology · 291
PDF
Current Applications of Nanoemulsions in Cancer Therapeutics
2019 · Elena Sánchez-López, Mariana Guerra, et al. · Nanomaterials · 276
PDF
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
2016 · Jaume Folch, Dmitry Petrov, et al. · Neural Plasticity · 270
PDF
Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8
2012 · David Porquet, Gemma Casadesús, et al. · AGE · 262
PDF
Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
2017 · Jaume Folch, Oriol Busquets, et al. · Journal of Alzheimer s Disease · 245
PDF
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations
2011 · David J Bonda, Hyoung-gon Lee, et al. · The Lancet Neurology · 221
Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease
2011 · Jaewon Chang, Agnes Rimando, et al. · Neurobiology of Aging · 217
Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease
2014 · Ignacio Pedrós, Dmitry Petrov, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 205
PDF
Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation
2008 · Pelayo Camps, Xavier Formosa, et al. · Journal of Medicinal Chemistry · 205
From Aging to Alzheimer's Disease: Unveiling “The Switch” with the Senescence-Accelerated Mouse Model (SAMP8)
2008 · Merce Pallas, Antoni Camins, et al. · Journal of Alzheimer s Disease · 198
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
2019 · Eliana B. Souto, João Dias-Ferreira, et al. · Pharmaceutics · 193
PDF
Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
2018 · Jordi Olloquequi, Elizabeth Cornejo-Córdova, et al. · Journal of Psychopharmacology · 189
Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
2009 · Merce Pallas, Gemma Casadesus, et al. · Current Neurovascular Research · 182
Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease
2014 · David Porquet, Christian Griñán-Ferré, et al. · Journal of Alzheimer s Disease · 177
PDF
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
2015 · Dmitry Petrov, Ignacio Pedrós, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 163
PDF
Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity
2003 · David Pubill, Anna M. Canudas, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 160
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—in vitro, ex vivo and in vivo characterization
2016 · E. Sánchez-López, M.A. Egea, et al. · Colloids and Surfaces B Biointerfaces · 150
Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases
2020 · Amanda Cano, Elena Sánchez-López, et al. · Nanomedicine · 144
PDF
Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM)
2005 · Anna M. Canudas, Javier Gutierrez-Cuesta, et al. · Mechanisms of Ageing and Development · 142
Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death
2011 · Jaume Folch, Felix Junyent, et al. · Neurotoxicity Research · 139
Early Amyloid Accumulation in the Hippocampus of SAMP8 Mice
2010 · Jaume del Valle, Joaquim Duran-Vilaregut, et al. · Journal of Alzheimer s Disease · 134
Involvement of Calpain Activation in Neurodegenerative Processes
2006 · Antoni Camins, Ester Verdaguer, et al. · CNS Drug Reviews · 134
Protective effects of C-phycocyanin against kainic acid-induced neuronal damage in rat hippocampus
1999 · Victor Rimbau, Antoni Camins, et al. · Neuroscience Letters · 129
Works count: 432
Citation count: 17,440
H-index: 73
I10-index: 277
Year
Topic
Type